Reparixin: The Future of Laminitis Treatment?
Alexandra Beckstett
November 19, 2013
Brazilian researchers studied the drug reparixin’s effects on horses with experimentally induced laminitis.
Brazilian researchers studied the drug reparixin’s effects on horses with experimentally induced laminitis.
One researcher says it’s unlikely that every obese horse is at risk of developing EMS and laminitis.
The risk factors associated with laminitis are many. But which are most important for owners to watch for?
Researchers identified a number of novel laminitis risk factors, including management-level factors.
Owners will have an opportunity to talk to a panel of world-renowned experts about a variety of topics.
The International Equine Conference on Laminitis and Diseases of the Foot will take place Nov. 1-3 in Florida.
Leading laminitis researchers, scholars, clinicians, and farriers will present recent findings in November.
Farriers and veterinarians discuss ways to work together to treat laminitis–a devastating hoof disease.
Stem cells therapy might offer practitioners an additional treatment option for the fight against laminitis.
It’s important to have at least an understanding of the structures in play during a laminitic episode.
A researcher says SIRS (systemic inflammatory response syndrome) is the term to use when discussing laminitis.
Endocrine disorders and black walnut extract exposure were a few of the causes researchers discussed.
The Obel Grading System is used to classify and understand laminitis progression in horses.
Recognizing clinical signs early and seeking immediate veterinary care can improve treatment outcomes.
MRI might offer evidence of laminitic changes in a horse’s hoof before the disease is otherwise identified.
This hand-forged shoe offers an option for supporting horses suffering laminitis.
Stay on top of the most recent Horse Health news with
